Posted On: 08/28/2014 12:03:34 PM
Post# of 30066
Well said Tanis, The BOD/BOA is the reason I'm invested here.
Kerry Segal
Head of Business Development
Kerry Segal heads-up all Business Development (both buy-side and sell-side) and M&A for Amarantus. Mr. Segal is a 30 year veteran of the biopharmaceutical industry, including very successful stints at J&J, Cephalon, Valeant, Impax and two start-ups. Mr Segal's illustrious career encompasses 22 years of front-line transactional experience during which time he has identified and closed transactions valued in excess of $2.6B and generated non-dilutive capital through partnerships in excess of $270MM. Mr Segal's forte is selectively identifying, pursuing, structuring and closing strategically prudent transactions that generate shareholder value.
Kerry Segal
Head of Business Development
Kerry Segal heads-up all Business Development (both buy-side and sell-side) and M&A for Amarantus. Mr. Segal is a 30 year veteran of the biopharmaceutical industry, including very successful stints at J&J, Cephalon, Valeant, Impax and two start-ups. Mr Segal's illustrious career encompasses 22 years of front-line transactional experience during which time he has identified and closed transactions valued in excess of $2.6B and generated non-dilutive capital through partnerships in excess of $270MM. Mr Segal's forte is selectively identifying, pursuing, structuring and closing strategically prudent transactions that generate shareholder value.
(0)
(0)
